<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2023</study_start_year><data_sharing_plan>IPD Sharing (as of September 2023): No</data_sharing_plan><condition>Metastatic Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><disease>Metastatic Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/92929</full_dataset_link><location>Egypt</location><study_start_month>3</study_start_month><keyword>Nitazoxanide</keyword><repository>ECRIN MDR</repository><study_status>Recruiting</study_status></additional><is_claimable>false</is_claimable><name>Nitazoxanide in Patients With Metastatic Colorectal Cancer</name><description>The aim of this study is to evaluate the potential efficacy and safety of nitazoxanide in patients with metastatic colorectal cancer.</description><dates><creation>2023-03-15</creation></dates><accession>92929</accession><cross_references><ClinicalTrials___gov>NCT06049901</ClinicalTrials___gov></cross_references></HashMap>